Evidence map›Paper›PMID 26807874›Full record

ReviewOcular immunology and inflammation2017

The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids.

Christine M Clemson, John Yost, Andrew W Taylor

Abstract readReview
In one paragraph

Review in Ocular immunology and inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Functional polymorphisms in pigmentation-related genesBiochemistry and biophysics reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. MC5R Contributes to Sensitivity to UVB Waves and Barrier Function in Mouse Epidermis.JID innovations : skin science from molecules to population health · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Adrenocorticotropic hormone gel for patients with non-infectious uveitis.American journal of ophthalmology case reports · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christine M Clemsona Autoimmune and Rare Diseases , Mallinckrodt Pharmaceuticals , Hayward , CA , USA.
John Yosta Autoimmune and Rare Diseases , Mallinckrodt Pharmaceuticals , Hayward , CA , USA.
Andrew W Taylorb Department of Ophthalmology , Boston University School of Medicine , Boston , MA , USA.

Funding

Manipulation of Immunity to Treat UveitisR01EY025961 · NEI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI TAYLOR, ANDREW W · 2016 to 2023
$3.3M
NEI NIH HHS R01 EY025961
6 · The paper itself

Abstract

Melanocortins are a highly conserved family of peptides and receptors that includes multiple proopiomelanocortin-derived peptides and five defined melanocortin receptors. The melanocortins have an important role in maintaining immune homeostasis and in suppressing inflammation. Within the healthy eye, the melanocortins have a central role in preventing inflammation and maintaining immune privilege. A central mediator of the anti-inflammatory activity is the non-steroidogenic melanocortin peptide alpha-melanocyte stimulating hormone. In this review we summarize the major findings of melanocortin regulation of ocular immunobiology with particular interest in the ability of melanocortin to induce immune tolerance and cytoprotection. The melanocortins have therapeutic potential because their mechanisms of action in regulating immunity are distinctly different from the actions of steroids.

Indexed as

alpha-MSHEyeHormonesHumansImmune PrivilegeImmune SystemInflammationalpha-MSHHormonesalpha-MSHeyeglucocorticoidsmelanocortins

Identifiers

PMID26807874
PMCPMC5769144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.